Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Planning update |
| Buyer: | NHS England |
| Main Category: | Goods |
| Procurement Method: | Open procedure |
| Tender Status: | Pre-tender |
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Estimated Value
£63,000,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Estimated Value (ex. VAT): |
| £63,000,000 |
| Estimated Value (inc. VAT): | £75,600,000 |
| Release Date: | 26 March 2026 |
| Application Deadline: | — |
| Procurement ID (OCID): | ocds-h6vhtk-0668be |
| Notice Reference: | 028180-2026 |
Ready to bid on this contract?
BidWriter AI writes your tender response in minutes — import this contract in one click.
View Original Notice
Access the full notice on the official portal
Inclusion of additional strength
NHS National Framework Tenofovir alafenamide/Emtricitabine 200/10mg & 200/25mg (Descovy or eqv) Suppliers who are planning to introduce the molecules detailed in the framework title, or who have any questions regarding a potential upcoming procurement exercise, are invited to contact the MPSC New Market Developments Team. Please email [email protected], [email protected], and [email protected]